Madison Sustainable Equity Fund highlighted stocks like Equifax Inc. (NYSE:EFX) in the Q3 2024 investor letter. Equifax Inc. ...

In a report released today, Andrew Steinerman from J.P. Morgan maintained a Buy rating on Equifax (EFX – Research Report), with a price target ...

JPMorgan analyst Andrew Steinerman lowered the firm’s price target on Equifax (EFX) to $283 from $304 and keeps an Overweight rating on the ...

Equifax EFX is benefiting from its new EFX Cloud Data Fabric, and the innovation of its products using AI and ML. However, ...

Enerflex Ltd. (TSE:EFX – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Acumen Capital raised their price target on the stock from C$12.00 to C$15.00. The ...

On Friday, Equifax Inc (EFX) stock saw a decline, ending the day at $248.27 which represents a decrease of $-13.94 or -5.32% from the prior close of $262.21. The stock opened at $257.81 and touched a ...

"The third quarter of 2024 marked an important milestone for EFX with the first patient dosed in the Phase 3 SYNCHRONY ...

It has been about a month since the last earnings report for Equifax (EFX). Shares have lost about 6.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Enerflex (TSE:EFX – Free Report) had its target price raised by BMO Capital Markets from C$11.00 to C$15.00 in a report ...

In the latest quarter, 11 analysts provided ratings for Equifax EFX, showcasing a mix of bullish and bearish perspectives.

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver ...